After Beating Estimates, Is This Little-Known Medical Device Company a Buy?

After Beating Estimates, Is This Little-Known Medical Device Company a Buy?·Motley Fool
In this article:

AngioDynamics exceeded analyst expectations on revenue in Q4 2021, but does that make it worth buying?

Advertisement